CRO’s are looking for a proven platform- so they don’t have to spend time and money to build.

Hybrid virtual visits model ideal for

Phase III and Phase IV post-marketing trials.

Ideal for long term observational trials.

  • Ideal for Survivability visits.
  • Ideal for Outcome trials.
  • Ideal for rare disease indications.
  • Ideal for centralized ratings-CNS trials.

Protected view access to reporting dashboard to view patient compliance.

Virtually certified SCRS member sites = easier/quicker hybrid study start up.